-
IntroducedFeb 10, 2023
-
Passed Senate
-
Passed House
-
Signed into Law
Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.
Last Action See all actions
Senate • Apr 30, 2024: Died in Committee
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on SB 236
Tweets
Whip Lists
Sponsors
- Committee on Public Health and Welfaresponsor
Votes
Actions
- Apr 30, 2024 | Senate
- Died in Committee
- Feb 13, 2023 | Senate
- Referred to Committee on Financial Institutions and Insurance
- Feb 10, 2023 | Senate
- Introduced
Bill Texts
Documents